Moderna

$172.37

-$1.90 (-1.09%) As of 6:45 PM UTC today
1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Moderna and other ETFs, options, and stocks.

About MRNA

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. 

CEO
Stéphane Bancel
CEOStéphane Bancel
Employees
2,700
Employees2,700
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2010
Founded2010
Employees
2,700
Employees2,700

MRNA Key Statistics

Market cap
68.56B
Market cap68.56B
Price-Earnings ratio
5.31
Price-Earnings ratio5.31
Dividend yield
Dividend yield
Average volume
5.34M
Average volume5.34M
High today
$179.85
High today$179.85
Low today
$172.25
Low today$172.25
Open price
$174.04
Open price$174.04
Volume
2.48M
Volume2.48M
52 Week high
$464.85
52 Week high$464.85
52 Week low
$115.61
52 Week low$115.61

MRNA News

Benzinga 3d
Looking Into Moderna's Recent Short Interest

Moderna's (NASDAQ:MRNA) short percent of float has risen 14.18% since its last report. The company recently reported that it has 16.29 million shares sold short...

Looking Into Moderna's Recent Short Interest

Analyst ratings

53%

of 19 ratings
Buy
42.1%
Hold
52.6%
Sell
5.3%

MRNA Earnings

-$0.69
$3.30
$7.30
$11.29
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
$4.59 per share
Estimated$4.59 per share
Actual
$5.24 per share
Actual$5.24 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.